Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion type Assertion NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_head.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion description "[To identify the promising alternative approach, we investigated the therapeutic potential of targeting the interleukin (IL)-8/CXCR2 pathway in colon cancer treatment using both loss-of-function (CXCR2 knockout) and gain-of-function (IL-8 overexpression) mouse models, as the IL-8/CXCR2 pathway has been shown to be activated in intestinal tumors of both human and experimental animals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion evidence source_evidence_literature NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion SIO_000772 24338666 NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion wasDerivedFrom befree-2016 NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.
- NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_assertion wasGeneratedBy ECO_0000203 NP1137020.RAgRl8XIvx_QO0JnSwQgLOWU0o_jZ0Jc4TUEiW4LOjHgo130_provenance.